Expand TARA Menu
TARA MENU

TARA Latest Press Releases

-- December 4, 2025 --

Protara Announces Pricing of $75 Million Public Offering Globe Newswire 10:03 PM
Protara Announces Proposed Public Offering Globe Newswire 4:15 PM

-- December 3, 2025 --

Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Nave NMIBC Patients Globe Newswire 8:00 AM

-- December 1, 2025 --

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Nave NMIBC Patients on Wednesday, December 3, 2025 Globe Newswire 4:15 PM

-- November 19, 2025 --

Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations Globe Newswire 8:00 AM

-- November 18, 2025 --

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025 Globe Newswire 4:30 PM

-- November 17, 2025 --

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Nave NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology Globe Newswire 8:00 AM

-- November 10, 2025 --

Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 8:00 AM

-- November 4, 2025 --

Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace Globe Newswire 4:05 PM

-- October 1, 2025 --

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:03 PM

-- September 2, 2025 --

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 11, 2025 --

Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 8:00 AM

-- August 1, 2025 --

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:08 PM
Market Data Delayed 15 Minutes